These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20382977)

  • 1. Possible mechanisms of left ventricular torsion evaluated by cardioreparative effects of telmisartan in patients with hypertension.
    Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Ara N; Oki T
    Eur J Echocardiogr; 2010 Sep; 11(8):690-7. PubMed ID: 20382977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of telmisartan on left ventricular structure and function in patients with hypertension determined by two-dimensional strain imaging.
    Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Oki T
    J Hypertens; 2009 Sep; 27(9):1892-9. PubMed ID: 19506525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
    Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
    Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telmisartan improves morphologic and functional changes in both left ventricular myocardium and carotid arterial wall in patients with hypertension: assessment by tissue Doppler imaging and carotid ultrasonography.
    Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Oki T
    Echocardiography; 2010 Aug; 27(7):864-72. PubMed ID: 20456478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function.
    Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Oki T
    J Cardiol; 2010 Jan; 55(1):23-33. PubMed ID: 20122545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).
    Cowan BR; Young AA; Anderson C; Doughty RN; Krittayaphong R; Lonn E; Marwick TH; Reid CM; Sanderson JE; Schmieder RE; Teo K; Wadham AK; Worthley SG; Yu CM; Yusuf S; Jennings GL;
    Am J Cardiol; 2009 Dec; 104(11):1484-9. PubMed ID: 19932779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients.
    Petrovic I; Petrovic D; Vukovic N; Zivanovic B; Dragicevic J; Vasiljevic Z; Babic R
    J Int Med Res; 2005; 33 Suppl 1():39A-49A. PubMed ID: 16222899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy.
    Taniguchi I; Kawai M; Date T; Yoshida S; Seki S; Taniguchi M; Shimizu M; Mochizuki S
    Circ J; 2006 Aug; 70(8):995-1000. PubMed ID: 16864931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study.
    Galderisi M; Lomoriello VS; Santoro A; Esposito R; Olibet M; Raia R; Di Minno MN; Guerra G; Mele D; Lombardi G
    J Am Soc Echocardiogr; 2010 Nov; 23(11):1190-8. PubMed ID: 20810245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients].
    Petriĭ VV; Sergushkina NG; Brazhnik VA; Makolkin VI
    Ter Arkh; 2008; 80(12):13-6. PubMed ID: 19227900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
    Weinbergová O; Metelka R; Vymetal J; Konecný K; Kosatíková Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):69-73. PubMed ID: 15523550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
    Grandi AM; Solbiati F; Laurita E; Maresca AM; Nicolini E; Marchesi C; Gianni M; Guasti L; Venco A
    Am J Hypertens; 2008 Feb; 21(2):231-7. PubMed ID: 18174880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin II receptor blocker telmisartan: effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension].
    Ivanova OV; Fomicheva OA; Sergakova LM; Chernova NA; Rogoza AN; Karpov YA
    Kardiologiia; 2002; 42(2):45-9. PubMed ID: 12494207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension.
    Mattioli AV; Bonatti S; Monopoli D; Zennaro M; Mattioli G
    Blood Press; 2005; 14(5):273-8. PubMed ID: 16257872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients.
    Hasegawa H; Takano H; Narumi H; Ohtsuka M; Mizuguchi T; Namiki T; Kobayashi Y; Komuro I
    Hypertens Res; 2011 Nov; 34(11):1179-84. PubMed ID: 21796128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan.
    Mattioli AV; Zennaro M; Bonatti S; Bonetti L; Mattioli G
    Int J Cardiol; 2004 Dec; 97(3):383-8. PubMed ID: 15561322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with mild hypertensive heart disease and left ventricular outflow tract obstruction: treatment with angiotensin II antagonists.
    Nakagawa M; Sano N; Nobe S; Ichinose M; Yonemochi H; Saikawa T
    Heart Vessels; 2004 Sep; 19(5):248-51. PubMed ID: 15372301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of simvastatin on left ventricular hypertrophy and left ventricular function in patients with essential hypertension.
    Pan XD; Zeng ZH; Liang LY; Luo JD; Xiao AY; Lai Q; Wen YH; Lu DF; Wang W; He ZC; He WK
    Clin Exp Hypertens; 2011; 33(8):558-64. PubMed ID: 21957976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.